Digital Therapeutics Alliance
Digital Therapeutics Alliance CEO joins FDA Digital Health Advisory Committee and more digital heal…
Arrive AI appoints a former Elevance Health executive to its board, and CareAbout Health hires a seasoned digital health executive to be its new chief technology officer.
Jennifer Mathieu, senior vice president of professional and government affairs at AMCP, provides an update on the Access to Prescription Digital Therapeutics Act 2023 moving through Congress.
Alberta Spreafico, managing director of digital health and innovation at Healthware, shares how the report can guide companies' go-to-market strategies for entering the European market.
Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the market for digital therapeutics after Pear Therapeutics declared bankruptcy.
Some experts assert the legislation is preemptive and may stifle innovation, while others argue it has the potential to improve patient access to meaningful healthcare.
With many regulatory barriers clear, remaining roadblocks for digital therapeutics are cultural, lo…
Provider buy-in is more important than ever, digital therapeutics stakeholders say.
Also: FDA COVID-19 policy allows for remote use, digital modifications to ophthalmic devices; 23andMe launches genetics study to understand varying COVID-19 responses.
Also: Bardy Diagnostics names Ed Vertatschisch as next COO; Sapphire Digital names Kyle Raffaniello as permanent CEO.
The definition is broad, but an accompanying whitepaper attempts to pin down the category's place in the industry.
From syringes to workflow management systems, healthcare is no stranger to adopting new technologies into standard care.